Sava Infond’s Idexx Laboratories IDXX Stock Holding History

Sava Infond’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$94.8K	Hold	180	–	–	0.01%	224
2026 Q1	$101K	Buy	+180	New	+$115K	0.01%	214

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sava Infond's IDXX Position: Q2 2026 in Review

Sava Infond held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 180 shares worth $94.8K. The position accounts for 0.01% of the portfolio, ranked #224.

Sava Infond first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $101K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Sava Infond held 180 shares of Idexx Laboratories worth $94.8K as of Q2 2026.
Sava Infond left its Idexx Laboratories share count unchanged in Q2 2026.
Idexx Laboratories made up 0.01% of Sava Infond's portfolio in Q2 2026, its #224 holding.
Sava Infond first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
Sava Infond's Idexx Laboratories position peaked at $101K in Q1 2026.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.